Dalton Transactions p. 14756 - 14765 (2014)
Update date:2022-08-11
Topics:
Shu, Yao
Lei, Hao
Tan, Ying Ning
Meng, Miao
Zhang, Xiao Chun
Liu, Chun Y.
Three novel [Mo2]-bridge-[Mo2] complexes were synthesized by a convergent assembling reaction of the dimetal precursor Mo2(DAniF)3(O2CCH3) (DAniF = N,N′-di(p-anisyl)formamidinate) with the bridging ligands terephthalamidine, terephthalamide and dithioterephthalamide. The structures of these compounds, [Mo2(DAniF)3]2[μ-1,4-{C(E)NH}2-C6H4] (E = NH (1), O (2) or S (3)), were determined, either by X-ray crystallography or 1H NMR spectroscopy, to be the analogues of the terephthalate bridged dimolybdenum dimer. These compounds are structurally and electronically closely related by having the same structural skeleton and similar bonding parameters, which allowed us to analyze the differences between N, O and S atoms on the bridging ligand in promoting electronic interaction between the two [Mo2] units. In the electronic spectra, the metal to ligand charge transfer absorption bands, attributed to the HOMO (dδ) → LUMO (pπ) transition, was red shifted as the variable atoms change from N to O to S. The mixed-valence species 1+, 2+ and 3+, generated by one-electron oxidation of the neutral precursors and measured in situ, exhibited characteristic intervalence absorption bands, for which the energy and half-height bandwidth decreased from 1+ to 3+. Therefore, in comparison to O atoms, S atoms are capable of enhancing the electronic coupling between the two [Mo2] units, and the incorporation of N atoms to the bridging ligands slightly diminished the metal-metal interaction. The molecular structures and spectroscopic properties of these compounds were simulated by theoretical calculations at DFT level on the simplified models, which gave results consistent with the experimental observations. This journal is
View MoreShanghai PotentPharm Science and Technology Co.,Ltd
Contact:86-021-51969655
Address:Unit B, Building 18, No.300, Chuantu Rd,Pudong District, Shanghai 201202, China
Guangzhou Puho Pharmaceutical Technology Co. Ltd.
Contact:86-20-29848035/29848075
Address:No.166, Chaoyang East Road, Panyu District, Guangzhou City, Guangdong Province
website:http://www.simagchem.com
Contact:+86-592-2680277
Address:21/F Hualong Office Building,No.6 Hubin East Road, Xiamen,China
Heliosense Biotechnologies, Inc.
Contact:+86-592-5667290
Address:Xiamen Torch Hi-tech Zone Venture Weiye Building S506
Contact:+86 21 34123252
Address:14, 4580 Dushi, Shanghai, China
Doi:10.1002/cjoc.202000125
(2020)Doi:10.1021/jo01304a032
(1980)Doi:10.1016/S0040-4020(01)80393-8
(1993)Doi:10.1039/c39890000320
(1989)Doi:10.1016/S0021-9673(00)93785-3
(1977)Doi:10.1016/j.cclet.2011.03.017
(2011)